• Genetic influences on disease course and severity, 30 years after a clinically isolated syndrome 

  Sahi, Nitin; Haider, Lukas; Chung, Karen; Kanber, Baris; Samson, Rebecca; Tur Gomez, Carmen; Prados Carrasco, Ferran (Oxford University Press, 2023)

• Teriflunomide and Epstein–Barr virus in a Spanish multiple sclerosis cohort: in vivo antiviral activity and clinical response 

  Dominguez-Mozo, Maria Inmaculada; González-Suárez, Inés; Villar, Luisa M; Costa-Frossard França, Lucienne; Villarrubia, Noelia; Aladro, Yolanda; Montalban, Xavier; Comabella Lopez, Manuel (Frontiers Media, 2023-09-29)

• The OSCAR-MP Consensus Criteria for Quality Assessment of Retinal Optical Coherence Tomography Angiography 

  Wicklein, Rebecca; Yam, Charmaine; Noll, Christina; Aly, Lilian; Banze, Nicolas; Romahn, Eva Feodora; Cabello, Sergio; Vidal-Jordana, Angela (Wolters Kluwer Health, 2023-11)

• Do the current MS clinical course descriptors need to change and if so how? A survey of the MS community 

  Thompson, Alan; Moccia, Marcello; Calabresi, Peter; Finlayson, Marcia; Hawton, Annemarie; amato, Maria Pia; Montalban, Xavier (SAGE Publications, 2023-10)

• Safety and efficacy with alemtuzumab over 13 years in relapsing-remitting multiple sclerosis: final results from the open-label TOPAZ study 

  Coles, Alasdair; Traboulsee, Anthony; Singer, Barry A; Pozzilli, Carlo; Oreja-Guevara, C.; Achiron, Anat; Montalban, Xavier (SAGE Publications, 2023-09-21)

Más